Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Tax Provisions of $117000.0 for Q1 2026, up 123.4% year-over-year from $52372.4 in Q1 2025, and up 130.31% quarter-over-quarter from -$386000.0 in Q4 2025.
Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Tax Provisions for 17 consecutive years, with $117000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 123.4% year-over-year to $117000.0; the TTM figure through Mar 2026 stood at -$142000.0 (up 56.04% YoY), while the FY2025 annual figure was -$686000.0, down 259.53% from the prior year.
- Tax Provisions improved to $117000.0 in Q1 2026 per HBIO's latest filing, from -$386000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.0 million in Q2 2022 and bottomed at -$1.3 million in Q3 2022.
- Historically, Tax Provisions has averaged -$19176.5 across 5 years, with a median of $97000.0 in 2025.
- On a YoY basis, Tax Provisions climbed as much as 11157.14% in 2022 and fell as far as 697.67% in 2022.
- Harvard Bioscience's Tax Provisions stood at $774000.0 in 2022, then tumbled by 182.3% to -$637000.0 in 2023, then jumped by 136.11% to $230000.0 in 2024, then sank by 267.83% to -$386000.0 in 2025, then soared by 130.31% to $117000.0 in 2026.
- Business Quant data shows HBIO's Tax Provisions at $117000.0 in Q1 2026, -$386000.0 in Q4 2025, and $97000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 231.40 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 102.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -46.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 90.73 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 96.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 32.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 15.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 29.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 23.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | -386,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | -353,000.00 |
| Mar 31, 2024 | 210,000.00 |
| Dec 31, 2023 | -637,000.00 |
| Sep 30, 2023 | 677,000.00 |
| Jun 30, 2023 | -1.10 Mn |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 774,000.00 |
| Sep 30, 2022 | -1.29 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 215,000.00 |